The same studies reported tumor growth limiting activity upon PSMC2 knockdown in mouse prostate, breast, and gastric cancer models (Chen et al., 2021; Liu et al., 2022; Wang et al., 2021). The gene discussed is PSMC2; the disease is neoplasm.